TABLE 5.
Rating of factors affecting decision not to prescribe opioids for chronic noncancer pain
Factor affecting decision |
Rating, %
|
Total responses, n | ||
---|---|---|---|---|
Not important* | Neutral* | Important* | ||
Concern about long-term adverse effects, eg, addiction or misuse | 7 | 7 | 87 | 31 |
Lack of evidence for effectiveness of opioids in chronic noncancer pain | 16 | 16 | 66 | 32 |
Concern that patients complain of pain out of proportion to objective findings | 16 | 22 | 63 | 32 |
Type of practice limits follow-up, eg, walk-in clinic | 43 | 10 | 40 | 30 |
Concern about becoming a target prescriber of opioids | 34 | 22 | 38 | 32 |
Concern about audit by regulatory or monitoring body | 56 | 19 | 22 | 32 |
Concern about short-term adverse effects, eg, constipation, sedation | 47 | 31 | 19 | 32 |
Takes too much time to titrate and monitor | 66 | 16 | 16 | 32 |
Inadequate knowledge of dosages | 78 | 13 | 6 | 32 |
Inadequate knowledge of which opioids to use | 72 | 16 | 6 | 32 |
Per cent of respondents rating importance of factor as 1 or 2 (not important), 3 (neutral), or 4 or 5 (important) on 5-point Likert scale. Percentage may not total 100% because some respondents indicated ‘no opinion’